Adam Fine

Adam Fine is a General Partner & CEO at Windham Venture Partners. Adam has also worked with andros, NeuSpera Medical Inc., Personal Genome Diagnostics, Cureatr, Cartiva, Inc., Upward Health (formerly BehaveCare), VytronUS, and NUVAIRA, Inc.

Adam has over 20 years of experience in the medical device and healthcare IT industries. Adam has been involved in all aspects of product development, from idea generation through clinical adoption. Adam has also helped launch and grow several successful startups.

Adam earned their BA in Biology from Harvard University and their MBA from the Stanford Graduate School of Business.

Adam Fine has a MBA in Finance from New York University and a BA in International Relations from Boston University.

Shaun O'Connor - VP, Business Development, Lorne Taichman - Director, Science & Technology report to Adam Fine.